Literature DB >> 20876622

Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.

Aggeliki Poulou1, Nicholas Spanakis, Spyros Pournaras, Vassiliki Pitiriga, Kyriaki Ranellou, Fani Markou, Athanassios Tsakris.   

Abstract

OBJECTIVES: To investigate the extrahospital dissemination of carbapenem-resistant Klebsiella pneumoniae isolates and the mechanisms of acquired resistance.
METHODS: Patients who were referred to the outpatient department of Serres General Hospital with community-onset infections due to carbapenem-resistant K. pneumoniae isolates during August 2007-October 2008 were included in the study. The selected isolates were tested by determination of agar dilution MICs, phenotypic carbapenemase testing and PFGE. PCR and sequencing analyses were employed for identification of bla genes and mapping of the integron carrying the metallo-β-lactamase (MBL) gene. The location of the MBL allele was investigated by mating experiments, plasmid analysis and PCR assays.
RESULTS: Twenty-four carbapenem-resistant K. pneumoniae isolates causing urinary tract infections were recovered from 12 outpatients. Six of the patients presented with recurrent infections within a period of 1-6 months after the initial extrahospital isolation. All patients reported prior hospitalization within the preceding 4 months, whilst two were infected by carbapenem-resistant K. pneumoniae isolates during their previous hospitalization. Imipenem, meropenem and ertapenem MICs ranged from 8 to 64 mg/L, 4 to 32 mg/L and 8 to 128 mg/L, respectively. All studied isolates as well as those obtained from prior hospitalization belonged to a single PFGE clone. They harboured a plasmid-mediated bla(VIM-1) gene in an integron structure that has been previously described among K. pneumoniae isolates causing hospital-acquired infections in Greece.
CONCLUSIONS: This is the first study to document the dissemination of an MBL-producing K. pneumoniae strain in the community. The successful strain caused recurrent community-onset infections and was most likely acquired during patients' previous hospitalization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876622     DOI: 10.1093/jac/dkq363

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Dissemination of clinical isolates of Klebsiella oxytoca harboring CMY-31, VIM-1, and a New OXY-2-type variant in the community.

Authors:  Athanassios Tsakris; Aggeliki Poulou; Fani Markou; Vassiliki Pitiriga; Evangelia-Theophano Piperaki; Ioulia Kristo; Spyros Pournaras
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

2.  Rapid and sensitive detection of major uropathogens in a single-pot multiplex PCR assay.

Authors:  B Padmavathy; R Vinoth Kumar; Amee Patel; S Deepika Swarnam; T Vaidehi; B M Jaffar Ali
Journal:  Curr Microbiol       Date:  2012-04-22       Impact factor: 2.188

3.  Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort.

Authors:  Bryan T Alexander; Jonas Marschall; Robert J Tibbetts; Elizabeth A Neuner; W Michael Dunne; David J Ritchie
Journal:  Clin Ther       Date:  2012-06       Impact factor: 3.393

Review 4.  Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy.

Authors:  Constance Schultsz; Suzanne Geerlings
Journal:  Drugs       Date:  2012-01-01       Impact factor: 11.431

5.  Long-term care facilities: important participants of the acute care facility social network?

Authors:  Bruce Y Lee; Yeohan Song; Sarah M Bartsch; Diane S Kim; Ashima Singh; Taliser R Avery; Shawn T Brown; S Levent Yilmaz; Kim F Wong; Margaret A Potter; Donald S Burke; Richard Platt; Susan S Huang
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

6.  Analysis of drug resistance determinants in Klebsiella pneumoniae isolates from a tertiary-care hospital in Beijing, China.

Authors:  Bin Li; Yong Yi; Qi Wang; Patrick C Y Woo; Lin Tan; Hua Jing; George F Gao; Cui Hua Liu
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.